Obesity is associated with decreased µ-opioid but unaltered dopamine D2 receptor availability in the brain

Journal of Neuroscience

Volumn 35, Issue 9, 2015, Pages 3959-3965

  Karlsson, Henry K ^a   Tuominen, Lauri ^a,b   Tuulari, Jetro J ^a   Hirvonen, Jussi ^a,c   Parkkola, Riitta ^c   Helin, Semi ^a   Salminen, Paulina ^d   Nuutila, Pirjo ^a,e   Nummenmaa, Lauri ^a,f  

^a TURKU PET CENTRE   (Finland)

^b Departments of Psychiatry   (Finland)

^c Departments of Radiology   (Finland)

^d Departments Surgery   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f AALTO UNIVERSITY   (Finland)

Author keywords

Dopamine; Obesity; Opioids; Positron emission tomography; Receptors; Reward

Indexed keywords

CARFENTANIL; DOPAMINE 2 RECEPTOR; MU OPIATE RECEPTOR; RACLOPRIDE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIORAL APPROACH SYSTEM; BEHAVIORAL INHIBITION SYSTEM; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUTCH EATING BEHAVIOR QUESTIONNAIRE; FEMALE; HUMAN; MALE; META ANALYSIS; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; SIGNAL TRANSDUCTION; STATE TRAIT ANXIETY INVENTORY; TRAIT AND STATE FOOD CRAVINGS QUESTIONNAIRE; YALE FOOD ADDICTION SCALE; ANATOMY; BRAIN LEVEL; EATING; IMAGE PROCESSING; METABOLISM; MORBID OBESITY; PHYSIOLOGY; PSYCHOLOGY; SCINTISCANNING;

ADULT; ANATOMY, CROSS-SECTIONAL; BRAIN CHEMISTRY; EATING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; OBESITY, MORBID; POSITRON-EMISSION TOMOGRAPHY; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, MU;

EID: 84924793655     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4744-14.2015     Document Type: Article

References (52)

1. Berridge KC (2009) “Liking” and “wanting” food rewards: brain substrates and roles in eating disorders. Physiol Behav 97:537–550.
2. Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG (2010) The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 1350:43–64.
3. Cambridge VC, Ziauddeen H, Nathan PJ, Subramaniam N, Dodds C, Cham-berlain SR, Koch A, Maltby K, Skeggs AL, Napolitano A, Farooqi IS, Bullmore ET, Fletcher PC (2013) Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Biol Psychiatry 73:887–894.
4. Carpenter CL, Wong AM, Li Z, Noble EP, Heber D (2013) Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity (Silver Spring) 21:E467–E473.
5. de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B, Janssen IM, van de Laar A, Fliers E, Serlie MJ, Booij J (2011) Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res 1:37.
6. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitec-tonic maps and functional imaging data. Neuroimage 25:1325–1335.
7. Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 do-pamine receptor binding in the living human brain by PET. Science 231: 258–261.
8. Frost JJ, Wagner HN Jr, Dannals RF, Ravert HT, Links JM, Wilson AA, Burns HD, Wong DF, McPherson RW, Rosenbaum AE (1985) Imaging opiate receptors in the human brain by positron tomography. J Comput Assist Tomogr 9:231–236.
9. Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG, Pothos EN (2009) Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 159:1193–1199.
10. Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012) Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37:2643–2652.
11. Glass MJ, Billington CJ, Levine AS (1999) Opioids and food intake: distributed functional neural pathways? Neuropeptides 33:360–368.
12. Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M, Endres CJ, Dannals RF, Frost JJ (2005) Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57:1573–1582.
13. Gosnell BA, Levine AS (2009) Reward systems and food intake: role of opi-oids. Int J Obes (Lond) 33 [Suppl 2]:S54–S58.
14. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279–287.
15. Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD (2014) Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry 19:1078–1084.
16. Haghighi A, Melka MG, Bernard M, Abrahamowicz M, Leonard GT, Richer L, Perron M, Veillette S, Xu CJ, Greenwood CM, Dias A, El-Sohemy A, Gaudet D, Paus T, Pausova Z (2014) Opioid receptor mu 1 gene, fat intake and obesity in adolescence. Mol Psychiatry 19:63–68.
17. Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Nagren K, Kaasinen V (2007) Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 61:748–756.
18. Haltia LT, Rinne JO, Helin S, Parkkola R, Nagren K, Kaasinen V (2008) Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse 62:682–688.
19. Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DH, Schumann G, Machulla HJ, Bares R, Mann K (2005) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62:57–64.
20. Henriksen G, Willoch F (2008) Imaging of opioid receptors in the central nervous system. Brain 131:1171–1196.
21. Hirvonen J, Aalto S, Hagelberg N, Maksimow A, Ingman K, Oikonen V, Virkkala J, Någren K, Scheinin H (2009) Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects. Eur J Nucl Med Mol Imaging 36:275–286.
22. Jewett DM (1992) A simple synthesis of [11C]methyl triflate. Int J Rad Appl Instrum A 43:1383–1385.
23. Johnson PM, Kenny PJ (2010) Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 13:635–641.
24. Kenny PJ (2011) Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 12:638–651.
25. Koch T, Höllt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117:199–206.
26. Langer O, Nagren K, Dolle F, Lundkvist C, Sandell J, Swahn CG, Vaufrey F, Crouzel C, Maziere B, Halldin C (1999) Precursor synthesis and radio-labelling of the dopamine D-2 receptor ligand C-11 raclopride from C-11 methyl triflate. J Labelled Comp Radiopharm 42:1183–1193.
27. Larsen P, Ulin J, Dahlstrom K, Jensen M (1997) Synthesis of C-11 iodo-methane by iodination of C-11 methane. Appl Radiat Isot 48:153–157.
28. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009) Reward processingbythe opioid system in the brain. Physiol Rev 89:1379–1412.
29. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, Cook S, Broft A, Van Heertum R, Comer SD (2012) Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 71:192–198.
30. Michaelides M, Thanos PK, Kim R, Cho J, Ananth M, Wang GJ, Volkow ND (2012) PET imaging predicts future body weight and cocaine preference. Neuroimage 59:1508–1513.
31. Nathan PJ, O’Neill BV, Bush MA, Koch A, Tao WX, Maltby K, Napolitano A, Brooke AC, Skeggs AL, Herman CS, Larkin AL, Ignar DM, Richards DB, Williams PM, Bullmore ET (2012) Opioid receptor modulation of he-donic taste preference and food intake: a single-dose safety, pharmacoki-netic, and pharmacodynamic investigation with GSK1521498, a novel mu-opioid receptor inverse agonist. J Clin Pharmacol 52:464–474.
32. Peciña S, Berridge KC (2005) Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci 25:11777–11786.
33. Peciña S, Smith KS (2010) Hedonic and motivational roles of opioids in food reward: implications for overeating disorders. Pharmacol Biochem Behav 97:34–46.
34. Rosenthal R (1984) Meta-analytic procedures for social research. Beverly Hills, CA: Sage.
35. Rosenthal R, DiMatteo MR (2001) Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol 52:59–82.
36. Small DM, Jones-Gotman M, Dagher A (2003) Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19:1709–1715.
37. Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H, Kumar A, Brasic J, Wong DF (2010) Alterations ofcentral dopamine receptors before and after gastric bypass surgery. Obes Surg 20:369–374.
38. Stice E, Spoor S, Bohon C, Small DM (2008) Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322:449–452.
39. Tellez LA, Medina S, Han W, Ferreira JG, Licona-Limón P, Ren X, Lam TT, Schwartz GJ, de Araujo IE (2013) A gut lipid messenger links excess dietary fat to dopamine deficiency. Science 341:800-802.
40. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289.
41. Volkow ND, Wise RA (2005) How can drug addiction help us understand obesity? Nat Neurosci 8:555–560.
42. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K (1996) Decreases in dopamine receptors but not in dopamine transportersinalcoholics. Alcohol Clin Exp Res 20:1594–1598.
43. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015–2021.
44. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K (2008) Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42:1537–1543.
45. Volkow ND, Wang GJ, Baler RD (2011) Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 15:37–46.
46. Volkow ND, Wang GJ, Tomasi D, Baler RD (2013) Obesity and addiction: neurobiological overlaps. Obes Rev 14:2–18.
47. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354–357.
48. Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, Frost JJ, McCaul ME (2011) Positron emission tomography imaging of mu-and delta-opioid receptor binding inalcohol-dependent and healthy control subjects. Alcohol Clin Exp Res 35:2162–2173.
49. Whistler JL (2012) Examining the role of mu opioid receptor endocytosis in the beneficial and side-effectsofprolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:189–204.
50. Yeomans MR, Gray RW (2002) Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26:713–728.
51. Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M, Tao WX, Napolitano A, Skeggs AL, Brooke AC, Cheke L, Clayton NS, Sadaf Farooqi I, O’Rahilly S, Waterworth D, Song K, Hosking L, Richards DB, Fletcher PC, Bullmore ET (2013) Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry 18:1287–1293.
52. Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ (1996) Increased mu opioid receptor binding detected by PET in cocaine-dependent men isassociated with cocaine craving. Nat Med 2:1225–1229.